MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Vertex Pharmaceuticals Incorporated Company Profile (NASDAQ:VRTX)

Consensus Ratings for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (?)
Ratings Breakdown: 7 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $143.50 (12.53% upside)

Current Analysts' Coverage Summary for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Show:
DateFirmActionRatingPrice TargetActions
7/31/2015Deutsche BankReiterated RatingBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015JMP SecuritiesReiterated RatingBuy$145.00 -> $148.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015HC WainwrightReiterated RatingNeutral$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015William BlairBoost Price TargetOutperform$138.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015Morgan StanleyLower Price Target$120.00 -> $119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2015BTIG ResearchLower Price TargetBuy$200.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Piper JaffrayReiterated RatingOverweight$146.00 -> $161.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Leerink SwannReiterated RatingOutperform$150.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Bank of AmericaBoost Price TargetNeutral$130.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/6/2015Robert W. BairdBoost Price TargetBuy$131.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2015Goldman SachsReiterated RatingBuy$142.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015RBC CapitalBoost Price TargetOutperform$130.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Canaccord GenuityReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Citigroup Inc.Boost Price TargetBuy$141.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Credit SuisseBoost Price TargetBuy$129.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Maxim GroupDowngradeBuy -> Hold$148.00 -> $121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Janney Montgomery ScottInitiated CoverageNeutral$126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BarclaysInitiated CoverageEqual Weight$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014CRT CapitalInitiated CoverageBuy$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Wells Fargo & Co.UpgradeNeutral -> Outperform$129.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2014Sanford C. BernsteinBoost Price Target$65.00 -> $107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2013Summer StreetDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2013Cowen and CompanyLower Price TargetNeutral$87.94 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha